Treatment and prevention of the amyloidoses: Can the lessons learned be applied to sporadic inclusion-body myositis?
- 27 June 2006
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 66 (12) , 1959
- https://doi.org/10.1212/01.wnl.0000227129.23385.04
Abstract
Recent advances in our understanding of the role of pyrin (both normal and mutated) in apoptosis and inflammation support this hypothesis. Colchicine, the drug for controlling the frequency and severity of FMF crises, may also …Keywords
This publication has 9 references indexed in Scilit:
- Treatment and prevention of the amyloidosesNeurology, 2006
- Familial Mediterranean fever associated pyrin mutations in GreeceAnnals of the Rheumatic Diseases, 2003
- Familial Mediterranean fever is no longer a rare disease in ItalyEuropean Journal of Human Genetics, 2003
- A Trial of Three Regimens for Primary Amyloidosis: Colchicine Alone, Melphalan and Prednisone, and Melphalan, Prednisone, and ColchicineNew England Journal of Medicine, 1997
- Treatment of 100 patients with primary amyloidosis: A randomized trial of melphalan, prednisone, and colchicine versus colchicine onlyThe American Journal of Medicine, 1996
- Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils.Journal of Clinical Investigation, 1995
- COLCHICINE TREATMENT OF AA AMYLOIDOSIS OF FAMILIAL MEDITERRANEAN FEVERArthritis & Rheumatism, 1994
- Survival of patients with primary (AL) amyloidosisThe American Journal of Medicine, 1987
- Primary systemic amyloidosis. Comparison of melphalan/prednisone versus colchicineThe American Journal of Medicine, 1985